This study demonstrated the feasibility of encapsulating thymic epithelial cells in permselective polymer membranes as a potential treatment for immunodeficiency diseases. Pure thymic epithelial cell cultures were obtained from fetal mouse thymus and confirmed by electron microscopy and keratin staining. After encapsulation, cells remained intact and produced physiologic amounts of thymosin alpha-1 for at least 5 days. The polymer membrane allows thymic hormone passage while preventing antibody, complement, cell, and virus entry, potentially enabling immune reconstitution without tissue rejection.
Christenson, L; Aebischer, P; Galletti, P M